Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials
Year: 2025
Type: review
Source: Nature Reviews Urology
Authors: Daniel J. Benedetti, Nicholas G. Cost, Peter F. Ehrlich, Nicholas Evageliou, Elizabeth Fialkowski, Lauren N. Parsons, Kelly L. Vallance, Lindsay A. Renfro, Andrew L. Hong, Jennifer H. Aldrink, Luke Pater, Arnold C. Paulino, Jesse K. Sandberg, Ethan A. Smith, Amy L. Treece, Jeffrey S. Dome, James I. Geller, Elizabeth A. Mullen
Institutions: Vanderbilt University Medical Center, Children's Hospital Colorado, University of Colorado Anschutz, University of Michigan, Children's Hospital of Philadelphia, Oregon Health & Science University, Children's Hospital of Wisconsin, Medical College of Wisconsin, Cook Children's Medical Center, University of Southern California, Children's Oncology Group, Emory University, Children's Healthcare of Atlanta, Nationwide Children's Hospital, The Ohio State University, University of Cincinnati, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Cincinnati Children's Hospital Medical Center, Children's of Alabama, Children's National, George Washington University, Boston Children's Hospital, Dana-Farber Cancer Institute
Language: English
Topic: Renal and related cancers
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4411487564